My bookmarksSign up free

Commission Implementing Regulation (EU) 2017/419 ANNEX II

Commission Implementing Regulation (EU) 2017/419 ANNEX II

ANNEX IISupplementary provisions

ANNEX II In Part C of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added: Number Common Name, Identification Numbers IUPAC Name Purity  ( *1 ) Date of approval Specific provisions ‘14 Urtica spp. CAS No 84012-40-8 ( Urtica dioica extract) CAS No 90131-83-2 ( Urtica urens extract) Urtica spp. European Pharmacopeia 30 March 2017 Urtica spp. shall be used in accordance with the specific conditions included in the conclusions of the review report on Urtica spp. (SANTE/11809/2016) and in particular Appendices I and II thereof.’ ( *1 )   Further details on identity, specification and manner of use of basic substance are provided in the review report.

Read the full instrument →

Other provisions in Commission Implementing Regulation (EU) 2017/419

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX II of Commission Implementing Regulation (EU) 2017/419 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next